Stay updated on Ertugliflozin in Pediatric T2DM Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.

Latest updates to the Ertugliflozin in Pediatric T2DM Clinical Trial page
- Check6 days agoChange DetectedThe website footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check13 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry Revision: v3.7.0 was added to the study's history, indicating an updated version of the record on ClinicalTrials.gov. The previous Revision: v3.6.6 entry was removed from the visible history, reflecting the current set of revisions.SummaryDifference0.0%

- Check49 days agoChange DetectedProvided data contains no additions or deletions to evaluate. There are no substantive text changes described beyond the existing version history.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page's revision banner now shows Revision: v3.6.6, replacing Revision: v3.6.5. This is a minor update to the page's metadata and does not affect the study data or user-facing content.SummaryDifference0.0%

- Check77 days agoChange DetectedThe revision tag in the page footer updated from v3.6.4 to v3.6.5. This reflects a platform/UI update that does not modify study data or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Ertugliflozin in Pediatric T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.